Edexcel S4 — Question 3 13 marks

Exam BoardEdexcel
ModuleS4 (Statistics 4)
Marks13
PaperDownload PDF ↗
Mark schemeDownload PDF ↗
TopicHypothesis test of binomial distributions
TypeCalculate Type I error probability
DifficultyStandard +0.8 This is a comprehensive S4 hypothesis testing question requiring multiple calculations (Type I error, power function, critical region determination) across two different scenarios. While the individual techniques are standard for Further Maths S4, the question demands sustained accuracy across 7 parts, understanding of power vs significance level trade-offs, and interpretation of results. The critical region calculation in part (d) requires trial-and-error with cumulative binomial probabilities to get 'as close as possible to 0.05', which is more demanding than routine textbook exercises.
Spec2.05a Hypothesis testing language: null, alternative, p-value, significance2.05c Significance levels: one-tail and two-tail5.02b Expectation and variance: discrete random variables5.02c Linear coding: effects on mean and variance

3. A certain vaccine is known to be only \(70 \%\) effective against a particular virus; thus \(30 \%\) of those vaccinated will actually catch the virus. In order to test whether or not a new and more expensive vaccine provides better protection against the same virus, a random sample of 30 people were chosen and given the new vaccine. If fewer than 6 people contracted the virus the new vaccine would be considered more effective than the current one.
  1. Write down suitable hypotheses for this test.
  2. Find the probability of making a Type I error.
  3. Find the power of this test if the new vaccine is
    1. \(80 \%\) effective,
    2. \(90 \%\) effective. An independent research organisation decided to test the new vaccine on a random sample of 50 people to see if it could be considered more than \(70 \%\) effective. They required the probability of a Type I error to be as close as possible to 0.05 .
  4. Find the critical region for this test.
  5. State the size of this critical region.
  6. Find the power of this test if the new vaccine is
    1. \(80 \%\) effective,
    2. \(90 \%\) effective.
  7. Give one advantage and one disadvantage of the second test.

Question 3:
Part (a)
AnswerMarks Guidance
\(H_0: p = 0.3\) (or 0.7), \(H_1: p < 0.3\) (or \(> 0.7\))B1 (1 mark)
Part (b)
Let \(X\) = number who contract virus. Under \(H_0\), \(X \sim B(30, 0.3)\)
AnswerMarks Guidance
\(P(\text{Type I error}) = P(X < 6 \mid p = 0.30) = P(X \leq 5) = 0.0766\)M1 A1 (2 marks)
Part (c)
AnswerMarks Guidance
(i) Power \(= P(Y \leq 5 \mid Y \sim B(30, 0.2)) = 0.4275\)M1 A1
(ii) Power \(= P(Y \leq 5 \mid Y \sim B(30, 0.1)) = 0.9268\)A1 (3 marks)
Part (d)
Let \(C\) = number who contract virus. Under \(H_0\), \(C \sim B(50, 0.3)\)
AnswerMarks Guidance
We require \(c\) such that \(P(C \leq c) \approx 0.05\)M1
\(P(C \leq 10) = 0.0789\), \(P(C \leq 9) = 0.0402\) \(\therefore\) critical region is \(C \leq 9\)A1 (2 marks)
Part (e)
AnswerMarks Guidance
Size \(= 0.0402\)B1 (1 mark)
Part (f)
AnswerMarks Guidance
(i) Power \(= P(D \leq 9 \mid D \sim B(50, 0.2)) = 0.4437\)B1
(ii) Power \(= P(D \leq 9 \mid D \sim B(50, 0.1)) = 0.9755\)B1 (2 marks)
Part (g)
AnswerMarks Guidance
Advantage: second test is more powerfulB1
Disadvantage: second test involves greater sample size, \(\therefore\) more expensive or takes longerB1 (2 marks) (13 marks total)
# Question 3:

## Part (a)
$H_0: p = 0.3$ (or 0.7), $H_1: p < 0.3$ (or $> 0.7$) | B1 | (1 mark)

## Part (b)
Let $X$ = number who contract virus. Under $H_0$, $X \sim B(30, 0.3)$

$P(\text{Type I error}) = P(X < 6 \mid p = 0.30) = P(X \leq 5) = 0.0766$ | M1 A1 | (2 marks)

## Part (c)
(i) Power $= P(Y \leq 5 \mid Y \sim B(30, 0.2)) = 0.4275$ | M1 A1 |

(ii) Power $= P(Y \leq 5 \mid Y \sim B(30, 0.1)) = 0.9268$ | A1 | (3 marks)

## Part (d)
Let $C$ = number who contract virus. Under $H_0$, $C \sim B(50, 0.3)$

We require $c$ such that $P(C \leq c) \approx 0.05$ | M1 |

$P(C \leq 10) = 0.0789$, $P(C \leq 9) = 0.0402$ $\therefore$ critical region is $C \leq 9$ | A1 | (2 marks)

## Part (e)
Size $= 0.0402$ | B1 | (1 mark)

## Part (f)
(i) Power $= P(D \leq 9 \mid D \sim B(50, 0.2)) = 0.4437$ | B1 |

(ii) Power $= P(D \leq 9 \mid D \sim B(50, 0.1)) = 0.9755$ | B1 | (2 marks)

## Part (g)
Advantage: second test is more powerful | B1 |

Disadvantage: second test involves greater sample size, $\therefore$ more expensive or takes longer | B1 | (2 marks) **(13 marks total)**

---
3. A certain vaccine is known to be only $70 \%$ effective against a particular virus; thus $30 \%$ of those vaccinated will actually catch the virus. In order to test whether or not a new and more expensive vaccine provides better protection against the same virus, a random sample of 30 people were chosen and given the new vaccine. If fewer than 6 people contracted the virus the new vaccine would be considered more effective than the current one.
\begin{enumerate}[label=(\alph*)]
\item Write down suitable hypotheses for this test.
\item Find the probability of making a Type I error.
\item Find the power of this test if the new vaccine is
\begin{enumerate}[label=(\roman*)]
\item $80 \%$ effective,
\item $90 \%$ effective.

An independent research organisation decided to test the new vaccine on a random sample of 50 people to see if it could be considered more than $70 \%$ effective. They required the probability of a Type I error to be as close as possible to 0.05 .
\end{enumerate}\item Find the critical region for this test.
\item State the size of this critical region.
\item Find the power of this test if the new vaccine is
\begin{enumerate}[label=(\roman*)]
\item $80 \%$ effective,
\item $90 \%$ effective.
\end{enumerate}\item Give one advantage and one disadvantage of the second test.
\end{enumerate}

\hfill \mbox{\textit{Edexcel S4  Q3 [13]}}